Iht Wealth Management, LLC Neurocrine Biosciences Inc Transaction History

Iht Wealth Management, LLC

  • $2.99 Billion
  • Q4 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 19, 2020
SELL
$96.16 - $135.15 $182,127 - $255,974
-1,894 Closed
0 $0
Q2 2020

Aug 14, 2020
BUY
$85.09 - $130.36 $161,160 - $246,901
1,894 New
1,894 $231,000
Q2 2018

Aug 13, 2018
SELL
$75.3 - $105.99 $1,882 - $2,649
-25 Closed
0 $0
Q3 2017

Nov 14, 2017
BUY
$47.97 - $61.28 $1,199 - $1,532
25
25 $2,000

Others Institutions Holding NBIX

# of Institutions
654
Shares Held
96.5M
Call Options Held
282K
Put Options Held
281K
View Full List

About NEUROCRINE BIOSCIENCES INC

NBIX Quotes by TradingView
  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $11.5B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Iht Wealth Management, LLC Portfolio

Follow Iht Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Iht Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Iht Wealth Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email